Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to compare the efficacy and toxicity of early stage endometrial cancer based on molecular classification and conventional risk stratification adjuvant therapy decision-making, and to provide high-quality evidence-based medical evidence for individualized adjuvant therapy selection under the guidance of fine stratification system of endometrial cancer.
Epistemonikos ID: f33d3b9aa04b088d13b6a43d4670320ba58a2717
First added on: May 13, 2024